Maurizio Voi Selected Research

Maurizio Voi Research Topics

Disease

14	Neoplasms (Cancer) 01/2019 - 09/2002
6	Tuberous Sclerosis (Bourneville's Disease) 10/2018 - 10/2016
4	Seizures (Absence Seizure) 10/2018 - 10/2016
4	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2018 - 11/2016
4	Renal Cell Carcinoma (Grawitz Tumor) 12/2017 - 03/2016
3	Disease Progression 11/2016 - 04/2005
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2013 - 12/2004
2	Hyperglycemia 01/2018 - 10/2016
2	Infections 01/2018 - 03/2016
2	Stomatitis 01/2018 - 03/2016
2	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 01/2018 - 01/2017
2	Angiomyolipoma 01/2018 - 01/2017
2	Breast Neoplasms (Breast Cancer) 10/2016 - 01/2004
2	Exanthema (Rash) 04/2005 - 12/2004
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Melanoma (Melanoma, Malignant) 01/2019
1	Hemorrhage 01/2017
1	Primitive Neuroectodermal Tumors (PNET) 01/2017
1	Flank Pain 01/2017
1	Hypercholesterolemia 10/2016
1	Fatigue 03/2016
1	Hepatocellular Carcinoma (Hepatoma) 01/2016
1	Hepatitis B 01/2016
1	Pericarditis 10/2014
1	Stomach Neoplasms (Stomach Cancer) 06/2013
1	Leukemia 10/2009
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2008
1	Hypersensitivity (Allergy) 04/2005
1	Febrile Neutropenia 04/2005
1	Diarrhea 04/2004
1	Nausea 04/2004
1	Renal Insufficiency (Renal Failure) 04/2004
1	Vomiting 04/2004

Drug/Important Bio-Agent (IBA)

15	Everolimus FDA Link 10/2018 - 01/2016
5	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2016
3	TOR Serine-Threonine KinasesIBA 01/2017 - 10/2016
2	trans-sodium crocetinate (crocetin)IBA 10/2018 - 01/2018
2	Anticonvulsants (Antiepileptic Drugs)IBA 01/2018 - 10/2016
2	Sunitinib (Sutent)FDA Link 01/2017 - 03/2016
2	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 01/2016
2	7- (4- (3- ethynylphenylamino)- 7- methoxyquinazolin- 6- yloxy)- N- hydroxyheptanamideIBA 10/2014 - 06/2013
2	Paclitaxel (Taxol)FDA LinkGeneric 04/2005 - 12/2004
2	Matrix Metalloproteinase InhibitorsIBA 04/2005 - 12/2004
2	N-((2S)-2-mercapto-1-oxo-4-(3,4,4- trimethyl- 2,5- dioxo- 1- imidazolidinyl)butyl)- L- leucyl- N,3- dimethyl-L-ValinamideIBA 04/2005 - 12/2004
2	Carboplatin (JM8)FDA LinkGeneric 04/2005 - 12/2004
2	7- cyano- 2,3,4,5- tetrahydro- 1- (1H- imidazol- 4- ylmethyl)- 3- (phenylmethyl)- 4- (2- thienylsulfonyl)- 1H- 1,4- benzodiazepine (BMS 214662)IBA 04/2005 - 04/2004
1	dabrafenibIBA 01/2019
1	trametinibIBA 01/2019
1	Chromogranin AIBA 01/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019
1	Phosphopyruvate Hydratase (Enolase)IBA 01/2019
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2019
1	lipoarabinomannan (LAM)IBA 01/2018
1	pazopanib FDA Link 12/2017
1	Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA 01/2017
1	GastrinsIBA 01/2017
1	Glucagon (Glukagon)FDA Link 01/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017
1	Cell-Free Nucleic AcidsIBA 10/2016
1	Estrogens (Estrogen)FDA Link 10/2016
1	LigandsIBA 10/2016
1	Estrogen ReceptorsIBA 10/2016
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	CreatinineIBA 10/2014
1	Cadherins (E-Cadherin)IBA 06/2013
1	Histone Deacetylases (Histone Deacetylase)IBA 08/2012
1	Histone Deacetylase InhibitorsIBA 08/2012
1	CUDC-907IBA 08/2012
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 08/2012
1	Dasatinib (BMS 354825)FDA Link 10/2009
1	Phosphotransferases (Kinase)IBA 01/2008
1	src-Family KinasesIBA 01/2008
1	pipoxolan (BR 18)IBA 04/2005
1	Farnesyltranstransferase (Farnesyltransferase)IBA 04/2005
1	Matrix Metalloproteinases (MMPs)IBA 12/2004
1	Transaminases (Aminotransferases)IBA 04/2004
1	Cisplatin (Platino)FDA LinkGeneric 04/2004
1	TransferasesIBA 04/2004
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2004
1	tesmilifene (DPPE)IBA 01/2004
1	taxaneIBA 09/2002
1	7-methylthiomethylpaclitaxel (BMS 184476)IBA 09/2002

Therapy/Procedure

6	Therapeutics 10/2018 - 04/2004
3	Nephrectomy 12/2017 - 01/2017
2	Drug Therapy (Chemotherapy) 04/2005 - 12/2004
1	Duration of Therapy 10/2016
1	Premedication 09/2002